Jefferies Financial Group Inc. Sc Pharmaceuticals Inc. Transaction History

Jefferies Financial Group Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$4.7 - $6.63 $1.15 Million - $1.63 Million	-245,550 Reduced 32.94%	500,000 $3.14 Million
Q3 2023 Nov 14, 2023	SELL	$7.0 - $9.82 $598,150 - $839,119	-85,450 Reduced 10.28%	745,550 $5.31 Million
Q2 2023 Aug 14, 2023	SELL	$8.94 - $11.74 $4.34 Million - $5.69 Million	-485,000 Reduced 36.85%	831,000 $8.47 Million
Q1 2023 May 15, 2023	BUY	$5.59 - $9.47 $7.36 Million - $12.5 Million	1,316,000 New	1,316,000 $11.9 Million

38.3M

121K

12.1K

Ticker SCPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,402,100
Market Cap $99.5M
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.